201 related articles for article (PubMed ID: 22733767)
1. Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.
Sengupta P; Basu S; Soni S; Pandey A; Roy B; Oh MS; Chin KT; Paraskar AS; Sarangi S; Connor Y; Sabbisetti VS; Kopparam J; Kulkarni A; Muto K; Amarasiriwardena C; Jayawardene I; Lupoli N; Dinulescu DM; Bonventre JV; Mashelkar RA; Sengupta S
Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11294-9. PubMed ID: 22733767
[TBL] [Abstract][Full Text] [Related]
2. Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy.
Paraskar AS; Soni S; Chin KT; Chaudhuri P; Muto KW; Berkowitz J; Handlogten MW; Alves NJ; Bilgicer B; Dinulescu DM; Mashelkar RA; Sengupta S
Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12435-40. PubMed ID: 20616005
[TBL] [Abstract][Full Text] [Related]
3. Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy.
Paraskar A; Soni S; Roy B; Papa AL; Sengupta S
Nanotechnology; 2012 Feb; 23(7):075103. PubMed ID: 22275055
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy.
Kulkarni AA; Roy B; Rao PS; Wyant GA; Mahmoud A; Ramachandran M; Sengupta P; Goldman A; Kotamraju VR; Basu S; Mashelkar RA; Ruoslahti E; Dinulescu DM; Sengupta S
Cancer Res; 2013 Dec; 73(23):6987-97. PubMed ID: 24121488
[TBL] [Abstract][Full Text] [Related]
5. Rationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacy.
Paraskar A; Soni S; Basu S; Amarasiriwardena CJ; Lupoli N; Srivats S; Roy RS; Sengupta S
Nanotechnology; 2011 Jul; 22(26):265101. PubMed ID: 21576779
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular PEGylated Dendritic Systems as pH/Redox Dual-Responsive Theranostic Nanoplatforms for Platinum Drug Delivery and NIR Imaging.
Li Y; Li Y; Zhang X; Xu X; Zhang Z; Hu C; He Y; Gu Z
Theranostics; 2016; 6(9):1293-305. PubMed ID: 27375780
[TBL] [Abstract][Full Text] [Related]
8. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin.
Brown SD; Nativo P; Smith JA; Stirling D; Edwards PR; Venugopal B; Flint DJ; Plumb JA; Graham D; Wheate NJ
J Am Chem Soc; 2010 Apr; 132(13):4678-84. PubMed ID: 20225865
[TBL] [Abstract][Full Text] [Related]
9. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
Datta P; Bang S; Yue Z; Beach T; Stilgenbauer M; Wang H; Bowers DJ; Kurokawa M; Xiao H; Zheng YR
Dalton Trans; 2020 Jun; 49(24):8107-8113. PubMed ID: 32490446
[TBL] [Abstract][Full Text] [Related]
10. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
11. Poly(β-cyclodextrin)/platinum prodrug supramolecular nano system for enhanced cancer therapy: Synthesis and in vivo study.
Zhang R; You X; Luo M; Zhang X; Fang Y; Huang H; Kang Y; Wu J
Carbohydr Polym; 2022 Sep; 292():119695. PubMed ID: 35725183
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models.
Zhang M; Hagan CT; Min Y; Foley H; Tian X; Yang F; Mi Y; Au KM; Medik Y; Roche K; Wagner K; Rodgers Z; Wang AZ
Biomaterials; 2018 Jul; 169():1-10. PubMed ID: 29631163
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin prodrug conjugated Fe
Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F
J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730
[TBL] [Abstract][Full Text] [Related]
15. Micellar nanoparticle formation via electrostatic interactions for delivering multinuclear platinum(II) drugs.
Xiao H; Stefanick JF; Jia X; Jing X; Kiziltepe T; Zhang Y; Bilgicer B
Chem Commun (Camb); 2013 May; 49(42):4809-11. PubMed ID: 23595166
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
17. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer.
Wang Y; Luo Z; Zhou D; Wang X; Chen J; Gong S; Yu Z
Biomater Sci; 2021 Jun; 9(11):4110-4119. PubMed ID: 33949442
[TBL] [Abstract][Full Text] [Related]
18. Coordination self-assembly of platinum-bisphosphonate polymer-metal complex nanoparticles for cisplatin delivery and effective cancer therapy.
Huang Y; He Y; Huang Z; Jiang Y; Chu W; Sun X; Huang L; Zhao C
Nanoscale; 2017 Jul; 9(28):10002-10019. PubMed ID: 28682411
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer.
Cho EJ; Sun B; Doh KO; Wilson EM; Torregrosa-Allen S; Elzey BD; Yeo Y
Biomaterials; 2015 Jan; 37():312-9. PubMed ID: 25453960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
